Skip to content

Training of Psychosocial Skills Based on Cognitive Behavioural Therapy for Patients With Parkinson's Disease

Basel Training Study II: Training of Psychosocial Skills for Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02048605
Acronym
CBT
Enrollment
30
Registered
2014-01-29
Start date
2014-02-28
Completion date
2017-01-31
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Parkinson's Disease

Brief summary

Patients with Parkinson's disease (PD) will be trained using a cognitive behavioral group-training-program to reduce stress and augment quality of life. An unspecific group with the same amount and frequency of meetings is used as a control group. For the evaluation of the training effects, scales to assess quality of life, analyses of psychopathological variations as well as neurocognitive tests will be used. Protocol amendment in 1-2017: addition of FU year 3 and year 5.

Interventions

BEHAVIORALPsycho-social CBT based training

Number of Sessions: 9x Content: cognitive behavioral group-training-program to reduce stress and augment quality of life.

BEHAVIORALUnspecific group training

Number of sessions: 9x Content: Music or Art Therapy Nutrition Education around Food Functional Movement Physical Activity Group discussion

Sponsors

Parkinson Schweiz
CollaboratorOTHER
Bangerter-Rhyner Foundation
CollaboratorUNKNOWN
AbbVie
CollaboratorINDUSTRY
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients with idiopathic Parkinson's disease according to United Kingdom Parkinson's Disease Brain Bank Criteria, being either cognitively normal, suffering from Mild Cognitive Impairment or having mild dementia. Patients must be able to give their written informed consent.

Exclusion criteria

* Moderate or severe dementia (DMS-IV, Mini Mental Status (MMS) \<24), other neurological or psychiatric diseases of the brain not related to PD, secondary parkinsonism, physical impairment hindering the adequate execution of the training, insufficient knowledge of German or pregnancy are

Design outcomes

Primary

MeasureTime frame
Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SeiQol-DW)Before and after 9 weeks of training, After 6-month

Secondary

MeasureTime frame
Scale for the assessment of management of daily living (Alltagsbewältigungsskala: A-B-S)Before and after 9 weeks training, after 6 month

Other

MeasureTime frameDescription
Burden questionnaire for Patients with Parkinson's Disease (Belastungsfragebogen)Before and after 9 weeks of training, after 6 monthQuestionnaire for measuring psychosocial problems, no official english translation available.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026